The WACC of Pharmesis International Ltd (BFK.SI) is 8.6%.
| Range | Selected | |
| Cost of equity | 7.60% - 10.80% | 9.20% |
| Tax rate | 0.80% - 3.40% | 2.10% |
| Cost of debt | 4.00% - 5.40% | 4.70% |
| WACC | 7.1% - 10.1% | 8.6% |
| Category | Low | High |
| Long-term bond rate | 2.7% | 3.2% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.96 | 1.16 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.60% | 10.80% |
| Tax rate | 0.80% | 3.40% |
| Debt/Equity ratio | 0.15 | 0.15 |
| Cost of debt | 4.00% | 5.40% |
| After-tax WACC | 7.1% | 10.1% |
| Selected WACC | 8.6% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for BFK.SI:
cost_of_equity (9.20%) = risk_free_rate (2.95%) + equity_risk_premium (5.60%) * adjusted_beta (0.96) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.